UK markets open in 1 hour 51 minutes

Danaher Corporation (DHR)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
313.38+2.64 (+0.85%)
At close: 4:03PM EDT

Danaher Corporation

2200 Pennsylvania Avenue, NW
Suite 800W
Washington, DC 20037-1701
United States
202 828 0850
http://www.danaher.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees67,000

Key executives

NameTitlePayExercisedYear born
Mr. Steven M. RalesCo-Founder & ChairmanN/AN/A1951
Mr. Rainer M. BlairPres, CEO & Director3.81M3.56M1964
Mr. Mitchell P. RalesCo-Founder & DirectorN/AN/A1957
Mr. Matthew R. McGrewCFO & Exec. VP2.46M959.67k1972
Mr. Brian W. EllisSr. VP, Gen. Counsel & Chief Compliance Officer1.93MN/A1967
Ms. Angela S. LalorSr. VP of HR3.11M13.66M1965
Mr. Joakim WeidemanisExec. VP2.94M3.16M1969
Mr. Robert S. LutzChief Accounting Officer & Sr. VPN/AN/A1958
Dr. Jose-Carlos Gutierrez-Ramos Ph.D.Sr. VP & Chief Science OfficerN/AN/A1964
Mr. Matthew E. Gugino C.F.A., CPAVP of Investor Relations and FP&AN/AN/AN/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Corporate governance

Danaher Corporation’s ISS governance QualityScore as of 26 September 2021 is 4. The pillar scores are Audit: 5; Board: 8; Shareholder rights: 3; Compensation: 4.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.